Cara Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Cassava Sciences USD 128.57M 20.4M 2024-12
Chugai Pharma JPY 423.42B 116.78B 2025-03
Cipla INR 8B 1.22B 2025-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 18.23M 11.01M 2024-12
CSL 1.52B 133M 2024-12
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 176.33M 60.48M 2025-03
J&J USD 38.47B 32.35B 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Pacira USD 283.61M 6.84M 2025-03
Pfizer USD 1.43B 387M 2025-03
RedHill Biopharma USD 7.28M 3K 2024-06
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12



Cara Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.